U18666A

CAS No. 3039-71-2

U18666A( —— )

Catalog No. M24233 CAS No. 3039-71-2

U18666A is a cell-permeable drug and is a cholesterol synthesis and transport inhibitor. It inhibits replication of Ebola virus, dengue virus, and human hepatitis C virus.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 35 In Stock
5MG 58 In Stock
10MG 88 In Stock
25MG 176 In Stock
50MG 305 In Stock
100MG 484 In Stock
200MG 691 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    U18666A
  • Note
    Research use only, not for human use.
  • Brief Description
    U18666A is a cell-permeable drug and is a cholesterol synthesis and transport inhibitor. It inhibits replication of Ebola virus, dengue virus, and human hepatitis C virus.
  • Description
    U18666A is a cell-permeable drug and is a cholesterol synthesis and transport inhibitor. It inhibits replication of Ebola virus, dengue virus, and human hepatitis C virus.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HCV
  • Recptor
    cholesterol transport|HCV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3039-71-2
  • Formula Weight
    424.06
  • Molecular Formula
    C25H42ClNO2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:50 mg/mL (117.91 mM; Need ultrasonic);H2O:10 mg/mL (23.58 mM; Need ultrasonic)
  • SMILES
    C[C@@]12[C@]3([H])[C@](CC=C1C[C@@H](OCCN(CC)CC)CC2)([H])[C@@]4([H])[C@@](C)(C(CC4)=O)CC3.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Poh MK, et al. U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication. Antiviral Res. 2012 Jan;93(1):191-8.
molnova catalog
related products
  • Dasabuvir

    ABT-333 is an NS5B non-nucleoside polymerase inhibitor.

  • MK-8325

    MK-8325 is a potent, selective pan-genotype HCV NS5A inhibitor with IC50 of 15, 1 and 3 pM for GT1a, GT1b and GT2a, respectively.

  • HCV-IN-4

    HCV-IN-4 is a potent and orally active HCV NS5A inhibitor, shows great potency against GT1a, GT2b, GT3a, GT1a Y93H and GT1a L31V, with EC90s of 3 pM, 0.3 nM, 0.01 nM, 0.5 nM and 0.02 nM, respectively.